Gene · 22937
Papers1,943
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,943
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms of 3-Hydroxyl 3-Methylglutaryl CoA Reductase in Alzheimer's Disease. | Int J Mol Sci | 2023 | 38203341 | PubTator, text mining | PubMed |
| Circadian clock and lipid metabolism disorders: a potential therapeutic strategy for cancer. | Front Endocrinol (Lausanne) | 2023 | 38189049 | PubTator, text mining | PubMed |
| Inhibition of lipid synthesis by the HIV integrase strand transfer inhibitor elvitegravir in primary rat oligodendrocyte cultures. | Front Mol Neurosci | 2023 | 38146334 | PubTator, text mining | PubMed |
| A Potential Intracanal Medicament, 2-Hydroxyisocaproic Acid (HICA): Cytotoxicity, Genotoxicity, and Its Effect on SCAP Differentiation. | Dent J (Basel) | 2023 | 38132408 | PubTator, text mining | PubMed |
| Benchmarking splice variant prediction algorithms using massively parallel splicing assays. | Genome Biol | 2023 | 38129864 | PubTator, text mining | PubMed |
| Exosome-based engineering strategies for the diagnosis and treatment of oral and maxillofacial diseases. | J Nanobiotechnology | 2023 | 38129853 | PubTator, text mining | PubMed |
| Lipid compartments and lipid metabolism as therapeutic targets against coronavirus. | Front Immunol | 2023 | 38106410 | PubTator, text mining | PubMed |
| Enhanced SREBP2-driven cholesterol biosynthesis by PKCλ/ι deficiency in intestinal epithelial cells promotes aggressive serrated tumorigenesis. | Nat Commun | 2023 | 38092754 | PubTator, text mining | PubMed |
| The role of extended synaptotagmin at membrane contact sites in cancer research. | Front Cell Dev Biol | 2023 | 38089882 | PubTator, text mining | PubMed |
| Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic. | Front Med (Lausanne) | 2023 | 38089874 | PubTator, text mining | PubMed |
| Exploring the impact of oral bacteria remnants on stem cells from the Apical papilla: mineralization potential and inflammatory response. | Front Cell Infect Microbiol | 2023 | 38089810 | PubTator, text mining | PubMed |
| Therapeutic protein PAK restrains the progression of triple negative breast cancer through degrading SREBP-1 mRNA. | Breast Cancer Res | 2023 | 38082285 | PubTator, text mining | PubMed |
| Adipose Tissue-Derived Mesenchymal Stem Cells Alter Metabolites of Brain Cholesterol Homeostasis in An Alzheimer's Model. | Cell J | 2023 | 38071408 | PubTator, text mining | PubMed |
| Dysregulated cholesterol regulatory genes in hepatocellular carcinoma. | Eur J Med Res | 2023 | 38071335 | PubTator, text mining | PubMed |
| Autophagy and Senescence: The Molecular Mechanisms and Implications in Liver Diseases. | Int J Mol Sci | 2023 | 38069199 | PubTator, text mining | PubMed |
| Secreted miR-210-3p, miR-183-5p and miR-96-5p reduce sensitivity to docetaxel in prostate cancer cells. | Cell Death Discov | 2023 | 38065937 | PubTator, text mining | PubMed |
| Targeting dysregulated lipid metabolism in the tumor microenvironment. | Arch Pharm Res | 2023 | 38060103 | PubTator, text mining | PubMed |
| Co-encapsulated astaxanthin and kaempferol nanoparticles: fabrication, characterization, and their potential synergistic effects on treating non-alcoholic fatty liver disease. | RSC Adv | 2023 | 38046630 | PubTator, text mining | PubMed |
| Potential therapies targeting nuclear metabolic regulation in cancer. | MedComm (2020) | 2023 | 38034101 | PubTator, text mining | PubMed |
| Reversible translocation of acyl-CoA:cholesterol acyltransferase (ACAT) between the endoplasmic reticulum and vesicular structures. | Front Mol Biosci | 2023 | 38028547 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/22937/papers?page=7